CTOs on the Move

Talaris Therapeutics

www.talaristx.com

 
Talaris Therapeutics is a late-clinical stage biotechnology company based in Boston, MA and Louisville, KY. Talaris is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe auto-immune and immune-mediated disorders. The company was founded on technology discovered and developed by Dr. Suzanne Ildstad and operates its own cell processing facility in Louisville. Talaris is backed by leading life sciences investors Blackstone Life Sciences, Longitude Capital and Qiming Venture Partners USA.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.talaristx.com
  • 201 East Jefferson Street Suite 110B
    Louisville, KY USA 40202
  • Phone: 502.569.1059

Executives

Name Title Contact Details
Michael Zdanowski
 Chief Technology Officer Profile
Eric Gornstein
 Head of New Product Planning Profile
Carlos Yuraszeck
 Senior Vice President of Technical Operations Profile

Funding

Talaris Therapeutics raised 4/18/2019 on 05/03/2019

Similar Companies

NephroGenex

NephroGenex is a Princeton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kinnos

Our patented and award-winning Highlight® technology makes it easy to use disinfectants correctly.

On Target

ON TARGET LABORATORIES discovers and develops fluorescent markers to target and illuminate cancer during surgery so it can be removed more completely.

Response Biomedical Corporation

Response Biomedical Corporation is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Axial Biotherapeutics

Axial Biotherapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and Central Nervous System to develop a new class of therapeutics to improve the quality of life for people with CNS diseases and disorders